James McClurkin

James McClurkin

Private Equity Investor bij Flagship Pioneering

Consumer Services
Finance
Miscellaneous

Oorsprong van het eerstegraads netwerk van James McClurkin

EntiteitType entiteitIndustrie
174
Private Company Investment Managers 174
Cleveland State University
41
College/University Other Consumer Services 41
1
Subsidiary Publishing: Books/Magazines 1

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met James McClurkin via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
Massachusetts Institute of Technology College/University

Noubar Afeyan

David Berry

Aram S. Adourian

Geoffrey von Maltzahn

Jacob Rubens

Nathan Stebbins

Yiqun Bai

Stephen Berenson

Hok Hei Tam

Sabrina Yang

Sean Murphy

David Xia

Director/Board Member

Doctorate Degree

Corporate Officer/Principal

Doctorate Degree

Doctorate Degree

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Graduate Degree

Graduate Degree

Undergraduate Degree

Graduate Degree

AXCA HEALPAR Biotechnology

John Mendlein

Noubar Afeyan

Michael Rosenblatt

Jeffrey Moore

David Berry

Geoffrey von Maltzahn

Gary Pisano

Robert L. Rosiello

Michael Hamill

Director/Board Member

Founder

Director/Board Member

Director of Finance/CFO

Founder

Founder

Director/Board Member

Chairman

Corporate Officer/Principal

Biotechnology

Noubar Afeyan

Geoffrey von Maltzahn

Avak Kahvejian

Gary Pisano

Molly Gibson

Michael Nally

Raffi Afeyan

Founder

Founder

Founder

Director/Board Member

Founder

Chief Executive Officer

President

EVELO BIOSCIENCES, INC. Pharmaceuticals: Major

Theo Melas-Kyriazi

Noubar Afeyan

Jeffrey Moore

David Berry

Robert L. Rosiello

Alexander Reynolds

Director/Board Member

Founder

Director/Board Member

Founder

Chairman

Director/Board Member

Biotechnology

Noubar Afeyan

Avak Kahvejian

Fabrice Chouraqui

Nicholas Plugis

Stephen Berenson

Raffi Afeyan

Founder

Founder

Chief Executive Officer

Founder

Chairman

President

Biotechnology

Michael T. Mack

David Berry

George Church

Ignacio Martinez

Robert Berendes

Robert L. Rosiello

Chairman

Founder

Founder

Founder

Director/Board Member

Director/Board Member

SERES THERAPEUTICS, INC. Biotechnology

Noubar Afeyan

David Berry

Geoffrey von Maltzahn

Stephen Berenson

Marcus Chapman

Founder

Founder

Founder

Chairman

Chief Operating Officer

Packaged Software

Noubar Afeyan

Ignacio Martinez

Hok Hei Tam

Kyle Chiang

Michael Wong

Director/Board Member

Director/Board Member

Founder

Chief Operating Officer

Founder

Harvard Business School College/University

Theo Melas-Kyriazi

Ed Kania

Gary Pisano

Robert L. Rosiello

Michael Nally

Masters Business Admin

Masters Business Admin

Corporate Officer/Principal

Masters Business Admin

Masters Business Admin

Biotechnology

Noubar Afeyan

David Berry

Geoffrey von Maltzahn

Ignacio Martinez

Robert Berendes

Founder

Founder

Founder

Director/Board Member

Chairman

Miscellaneous Commercial Services

Jonathan Ian Schwartz

Noubar Afeyan

Ignacio Martinez

Robert Berendes

Chief Executive Officer

Founder

Founder

Chairman

Miscellaneous Commercial Services

John Mendlein

Noubar Afeyan

Michael Rosenblatt

David Berry

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

College/University

Theo Melas-Kyriazi

Michael T. Mack

George Church

Aram S. Adourian

Undergraduate Degree

Masters Business Admin

Doctorate Degree

Doctorate Degree

MODERNA, INC. Biotechnology

Theo Melas-Kyriazi

John Mendlein

Noubar Afeyan

Stephen Berenson

Director/Board Member

Director/Board Member

Founder

Director/Board Member

Biotechnology

John Mendlein

Noubar Afeyan

Geoffrey von Maltzahn

Jacob Rubens

Director/Board Member

Founder

Director/Board Member

Founder

Biotechnology

Theo Melas-Kyriazi

Noubar Afeyan

Michael Rosenblatt

Avak Kahvejian

Director/Board Member

Founder

Director/Board Member

Founder

KALEIDO BIOSCIENCES, INC. Pharmaceuticals: Major

Theo Melas-Kyriazi

Noubar Afeyan

Jeffrey Moore

Geoffrey von Maltzahn

Chairman

Founder

Chief Administrative Officer

Founder

BG MEDICINE, INC. Medical Specialties

Harry Wilcox

Noubar Afeyan

Jeffrey Moore

Aram S. Adourian

Chairman

Founder

Director of Finance/CFO

Chief Tech/Sci/R&D Officer

RUBIUS THERAPEUTICS Biotechnology

Noubar Afeyan

Michael Rosenblatt

Avak Kahvejian

Andrew Oh

Founder

Director/Board Member

Founder

Director of Finance/CFO

Packaged Software

Noubar Afeyan

Ignacio Martinez

Robert Berendes

Stephen Berenson

Director/Board Member

Founder

Chairman

Director/Board Member

College/University

Jeffrey Moore

Aram S. Adourian

Kala Subramanian

Daniel Acker

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Pharmaceuticals: Other

Noubar Afeyan

Avak Kahvejian

Kala Subramanian

Erica Weinstein

Chairman

Chief Executive Officer

President

Founder

Biotechnology

Noubar Afeyan

Avak Kahvejian

Jason Gardner

Raffi Afeyan

Founder

Founder

Chief Executive Officer

Founder

Harvard Medical School College/University

Michael Rosenblatt

David Berry

George Church

Christopher P. Austin

Doctorate Degree

Graduate Degree

Corporate Officer/Principal

Doctorate Degree

MERCK & CO., INC. Pharmaceuticals: Major

Michael Rosenblatt

Rupert Vessey

Michael Nally

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

University of California San Diego College/University

Geoffrey von Maltzahn

Diego Miralles

Annie Vemu

Graduate Degree

Corporate Officer/Principal

Graduate Degree

CODIAK BIOSCIENCES Pharmaceuticals: Major

Theo Melas-Kyriazi

Noubar Afeyan

Avak Kahvejian

Director/Board Member

Director/Board Member

Director/Board Member

University of Massachusetts College/University

Bernie P Cooney

Nathashali Ortiz

Phil Woodburn

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Biotechnology

Theo Melas-Kyriazi

Noubar Afeyan

Volker Herrmann

Director/Board Member

Director/Board Member

President

University of Oxford College/University

Rupert Vessey

Jason Gardner

Alex Goldsmith

Doctorate Degree

Doctorate Degree

Undergraduate Degree

McGill University College/University

Noubar Afeyan

Avak Kahvejian

Raffi Afeyan

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Miscellaneous Commercial Services

John Mendlein

Noubar Afeyan

Stephen Berenson

Director/Board Member

Founder

Director/Board Member

Pharmaceuticals: Major

Noubar Afeyan

Michael Rosenblatt

Geoffrey von Maltzahn

Director/Board Member

Director/Board Member

Chief Executive Officer

OMEGA THERAPEUTICS, INC. Biotechnology

John Mendlein

Noubar Afeyan

David Berry

Director/Board Member

Founder

Founder

Chemicals: Major Diversified

Noubar Afeyan

David Berry

George Church

Founder

Founder

Founder

EXACT SCIENCES CORPORATION Medical Specialties

Harry Wilcox

Ed Kania

Noubar Afeyan

Director of Finance/CFO

Director/Board Member

Founder

Electronic Equipment/Instruments

Harry Wilcox

Noubar Afeyan

Ara Darzi

Chairman

Director/Board Member

Director/Board Member

T2 BIOSYSTEMS, INC. Medical Specialties

Harry Wilcox

Noubar Afeyan

David Berry

Director/Board Member

Director/Board Member

Founder

Miscellaneous Commercial Services

Harry Wilcox

Noubar Afeyan

Ignacio Martinez

Chairman

Director/Board Member

Director/Board Member

College/University

George Church

Kala Subramanian

Undergraduate Degree

Graduate Degree

Pharmaceuticals: Major

John Mendlein

Noubar Afeyan

Chief Executive Officer

Founder

ATYR PHARMA, INC. Pharmaceuticals: Major

John Mendlein

Kyle Chiang

Chief Executive Officer

Corporate Officer/Principal

Miscellaneous Commercial Services

John Mendlein

Tom DiLenge

Director/Board Member

General Counsel

Statistieken

Internationaal

Verenigde Staten 49
Verenigd Koninkrijk 2
Canada 2

Sectoraal

Health Technology 28
Consumer Services 10
Commercial Services 9
Technology Services 3
Process Industries 3

Operationeel

Director/Board Member 255
Founder 126
Corporate Officer/Principal 103
Undergraduate Degree 67
Private Equity Investor 65
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU